Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
EIR
•JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV•October 7, 2022

JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV – FDA EIR, Oct 7, 2022

Record Details

An FDA Postmarketing Adverse Drug Experience (PADE) surveillance inspection of Johnson and Johnson Consumer Inc, Div Of Mcneil,Inc. was conducted from October 4-7, 2022, in Fort Washington, PA. The inspection, guided by Compliance Program Guide 7353.001, focused on the company's pharmacovigilance processes for both approved (NDA/ANDA) and OTC Monograph drug products. A key finding was the successful remediation of issues from a 2014 inspection regarding untimely submission of expedited PADE reports. During this current inspection, no formal FDA Form 483 (Inspectional Observations) was issued. However, the inspection identified 457 late expedited adverse event cases, which the company attributed primarily to a technical mapping error in their global safety database and an increased reporting volume following a product recall. While no formal regulatory actions were mandated, discussions with management focused on the importance of ensuring adequate vendor oversight in reporting late cases, maintaining business partner compliance with adverse event submissions, and enhancing monitoring of all adverse event surveillance and receipt channels to ensure timely reporting. The company acknowledged these points for continuous improvement.

Company
JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
Inspection date
October 7, 2022
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Shalin Patel (recipient)
  • Lindsay Watt (company_representative)
  • Stefanie Emanuel (company_representative)
  • Edwin Kuffner (company_representative)
  • Philip Maltese (company_representative)
View Company Profile

ID · b1f3fc8a-e780-43c9-959f-d4cccc4717be

Violation Codes2
21 CFR 820.10021 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
  • EIR - 2021-05-03May 3, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore JOHNSON AND JOHNSON CONSUMER INC MCNEIL CONSUMER HEALTHCARE DIV
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.